MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1461 to 1480 of 166,322 approvalsPage 74 of 8317

Hydroxychloroquine Sulfate Tablets

Approval Number: 国药准字H20253361
Registration: Feb 11, 2025

Olopatadine Hydrochloride Eye Drops

Approval Number: 国药准字H20253371
Registration: Feb 11, 2025

Vitamin B₁₂ Eye Drops

Approval Number: 国药准字H20253367
Registration: Feb 11, 2025

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20253379
Registration: Feb 11, 2025

Oxygen

Approval Number: 国药准字H20253374
Registration: Feb 11, 2025

Oxygen

Approval Number: 国药准字H20253375
Registration: Feb 11, 2025

Beraprost Sodium Tablets

Approval Number: 国药准字H20253372
Registration: Feb 11, 2025

Lactulose Oral Solution

Approval Number: 国药准字H20253369
Registration: Feb 11, 2025

Lactulose Oral Solution

Approval Number: 国药准字H20253366
Registration: Feb 11, 2025

Bosentan Tablets

Approval Number: 国药准字HJ20250019
Registration: Feb 11, 2025
mylan s.p.a.

Telavancin Hydrochloride for Injection

Approval Number: 国药准字HJ20250017
Registration: Feb 11, 2025

Bosentan Tablets

Approval Number: 国药准字HJ20250018
Registration: Feb 11, 2025
mylan s.p.a.

Ezetimibe and Atorvastatin Calcium Tablets(Ⅱ)

Approval Number: 国药准字H20253380
Registration: Feb 11, 2025

Polyethylene Glycol Electrolytes Powder(III)

Approval Number: 国药准字H20253365
Registration: Feb 11, 2025

Compound Tropicamide Eye Drops

Approval Number: 国药准字H20253368
Registration: Feb 11, 2025

Levosalbutamol Hydrochloride Nebuliser Solution

Approval Number: 国药准字H20253376
Registration: Feb 11, 2025

Piroxicam Tablets

Approval Number: 国药准字H35020785
Registration: Feb 10, 2025

Lactulose Oral Solution

Approval Number: 国药准字H20253346
Registration: Feb 8, 2025

Talquetamab Injection

Approval Number: 国药准字SJ20250003
Registration: Feb 8, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.